Advertisement

Picture Berlin Partner Bionnale 2023 the Life Sciences Event 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in the Nordic Countries, Denmark, Finland, Iceland, Norway and Sweden, or involving organisations from these countries.

Total search results: 932 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Albireo–Ipsen: investment, 202301– cash tender offer $952m at $42/share plus 1 CVR/share entitling to $10/CVR 2023-01-09
Evosep–Novo Group: investment, 202301 minority investment of $40m by Novo Holdings A/S 2023-01-09
Affibody–EU (govt): credit, 202212– venture debt loan facility €20m from EIB supported by InvestEU programme 2022-12-22
Minervax–Adjuvant Capital: investment, 202212 financing round totalling €22m incl exisiting + co-investor Adjuvant Capital 2022-12-15
Minervax–Bellevue: investment, 202212 financing round totalling €22m incl new + co-lead investor Pureos Bioventures 2022-12-15
Minervax–EU (govt): credit, 202212 loan facility €50m from EIB 2022-12-15
Minervax–LF Investment: investment, 202212 financing round totalling €22m incl exisiting + co-investor LF Investment 2022-12-15
Minervax–Novo Group: investment, 202212 financing round totalling €22m incl exisiting + co-investor Novo REPAIR Impact Fund 2022-12-15
Minervax–Sanofi: investment, 202212 financing round totalling €22m incl exisiting + co-investor Sanofi Ventures 2022-12-15
Minervax–SEVERAL: investment, 202212 financing round €22m co-led by Trill Impact Ventures + Pureos Bioventures 2022-12-15
Minervax–Sunstone Life Science: investment, 202212 financing round totalling €22m incl exisiting + co-investor Sunstone Life Science Ventures 2022-12-15
Minervax–Sweden (govt): investment, 202212 financing round totalling €22m incl exisiting + co-investor Industrifonden 2022-12-15
Minervax–Trill Impact: investment, 202212 financing round totalling €22m incl new + co-lead investor Trill Impact Ventures 2022-12-15
Minervax–Wellington Partners: investment, 202212 financing round totalling €22m incl exisiting + co-investor Wellington Partners 2022-12-15
Chr. Hansen–Novozymes: investment, 202212– merger acquisition valuing Chr Hansen at DKK660.55/share ANNOUNCED 2022-12-12
Bico–Sartorius: investment, 202212– directed share issue SEK487m (€45m) to existing investor Sartorius resulting 10.1% share + 8.5% of voting rights 2022-12-08
Sartorius–Bico: laboratory equipment, 202212– collab RnD 3D cell printing technologies + digital soluitons for cell line development workflows 2022-12-08
Sartorius–Bico: laboratory equipment, 202212– distribution of Bico products in APAC region by Sartorius 2022-12-08
Hemispherian–Meneldor: investment, 202211 financing round Series A1 first tranche totalling NOK30m ($2.9m) incl existing + lead investor Meneldor 2022-11-24
Hemispherian–SEVERAL: investment, 202211 financing round Series A1 first tranche of NOK30m ($2.9m) led by Meneldor 2022-11-24
Accession Therapeutics–SEVERAL: investment, 202211 2nd financing round £16.6m incl iGlobe Partners + Primavera Venture Partners + Birk Venture 2022-11-21
Sarcura–Axilium Holding: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Axilium Holding 2022-11-17
Sartorius–SEVERAL: credit, 202211– placement of total of €650m Schulschein loans with 3, 5, 7, 10 + 13 years maturity 2022-11-11
BC Platforms–Jolt Capital: investment, 202211 growth financing round totalling CHF20m incl new + lead investor Jolt Capital 2022-11-08
BC Platforms–SEVERAL: investment, 202211 growth financing round CHF20m led by new investor Jolt Capital 2022-11-08
Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED 2022-10-31
Univ Copenhagen–Resolve Biosciences: Molecular Cartography technology, 202210 supply to Novo Nordisk Foundation Center existent 2022-10-24
Hemispherian–EU (govt): grant, 202210– grant €2.5m from EIC Accelerator programme 2022-10-19
Hemispherian–EU (govt): investment, 202210– equity financing €7.5m from EIC Fund RECOMMENDED 2022-10-19
MS-Omics–Clinical Microbiomics: investment, 202210 acquisition of MS-Omics ApS by Clinical Microbiomics A/S 2022-10-17
Clinical Microbiomics–BPCE: investment, 202210 investment €10m from Health for Life Capital II fund managed by Seventure Partners 2022-10-11
Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva 2022-10-06
Novo Group–Ventus Therapeutics: NLRP3 inhibitor, 202209– excl ww developm + license agreem $70m upfront + $633m milestones for lead program 2022-09-29
Novo Group–Microsoft: AI-based drug discovery, 202209 collab strategic combining MS computation services + cloud + AI with Novo RnD + data science 2022-09-12
Pretzel Therapeutics–SEVERAL: investment, 202209 financing round Series A $72.5m led by ARCH Venture Partners + Mubadal Capital 2022-09-12
Pretzel Therapeutics–Ten Bridge Communications: public relations, 202209 service existent Ten Bridge is media contact 2022-09-12
Onego Bio–Finland (govt): grant, 202209 grant €4.5m from Business Finland 2022-09-07
Forma Therapeutics–Novo Group: investment, 202209– acquisition $1.1b cash tender of by Novo Nordisk at $20/share 2022-09-01
eTheRNA–EQT: investment, 202208 financing round Series B2 totalling €39m incl existing + co-investor EQT Life Sciences (formerly LSP) 2022-08-23
eTheRNA–PERSON: investment, 202208 financing round Series B2 totalling €39m incl new + co-investor Kenneth Chien 2022-08-23
eTheRNA–SEVERAL: investment, 202208 financing round Series B2 €39m led by existing investor Novalis LifeSciences LLC 2022-08-23
Albumedix–Sartorius: investment, 202208–202209 acquisition £415m 100% of Albumedix by Sartorius Stedim Biotech 2022-08-08
Atlas Antibodies–Genovis: MS-based analysis of biopharmaceuticals, 202208– supply service LC-MS analytics of recombinant CHO-antibodies to Evitria 2022-08-08
Genmab–BioNTech: cancer immunotherapy, 202208– collab expansion 50/50 cost + profit sharing developm + commercn monospeific antibodies using HexaBody 2022-08-05
Active Biotech–SEVERAL: investment, 202208– rights issue up to SEK54.5m with up to 54.5m new shares at SEK1/share 2022-08-04
SHS Capital–Realdania: investment, 202207 first closing totalling over €220m of SHS VI fund incl investor Realdania Foundation 2022-07-18
SHS Capital–SEVERAL: investment, 202207 first closing at over €220m of SHS VI fund with EIF + Realdania + Helsana HealthInvest + LBBW et al. 2022-07-18
Navinci Diagnostics–Beijer Ventures: investment, 202207 financing round Series A totalling SEK90m incl existing + co-investor Beijer Ventures AB 2022-07-12
Navinci Diagnostics–Landegren Gene Technology: investment, 202207 financing round Series A totalling SEK90m incl existing + co-investor LGT 2022-07-12
Navinci Diagnostics–Nexttobe: investment, 202207 financing round Series A totalling SEK90m incl existing + co-investor Nexttobe AB 2022-07-12
Navinci Diagnostics–Segulah Medical Acceleration: investment, 202207 financing round Series A totalling SEK90m incl new + lead investor SMA 2022-07-12
Navinci Diagnostics–SEVERAL: investment, 202207 financing round Series A SEK90m led by new investor Segulah Medical Acceleration 2022-07-12
Biosyntia–ECBF: investment, 202207 financing round Series B totalling €11.5m incl new + lead investor ECBF 2022-07-07
Biosyntia–Novo Group: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Novo Seeds 2022-07-07
Biosyntia–SEVERAL: investment, 202207 financing round Series B €11.5m led by new investor ECBF 2022-07-07
Biosyntia–Sofinnova: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Sofinnova Partners 2022-07-07
BioPhero–FMC: investment, 202206– acquisition $200m at closing of BioPhero by FMC ANNOUNCED 2022-06-29
SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures 2022-06-22
CH-Bioforce–EU (govt): grant, 202206– EIC Accelerator programme grant up to €15m to advance biomass processing plant 2022-06-21
Elypta–Bonnier: investment, 202206 financing round Series A totalling $21m incl lead investor Bonnier Ventures 2022-06-20
Elypta–Chalmers Univ: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Chalmers Ventures 2022-06-20
Elypta–Hillclimber: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Hillclimber 2022-06-20
Elypta–Nina Capital: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Nina Capital 2022-06-20
Elypta–Norrsken Foundation: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Norrsken VC 2022-06-20
Elypta–SEVERAL: investment, 202206 financing round Series A $21m led by Bonnier Ventures 2022-06-20
Elypta–Sweden (govt): investment, 202206 financing round Series A totalling $21m incl existing + co-investor Industrifonden 2022-06-20
Elypta–Wallenberg: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Navigare Ventures 2022-06-20
ImCheck Therapeutics–EQT: investment, 202206 financing round Series C totalling €80m incl existing + co-investor EQT Life Sciences 2022-06-13
Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine 2022-06-09
Ariceum Therapeutics–Bellevue: investment, 202206 financing round Series A totalling €25m incl co-investor Pureos Bioventures 2022-06-08
Ariceum Therapeutics–EQT: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor EQT Life Sciences 2022-06-08
Ariceum Therapeutics–Odlander Fredrikson: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor HealthCap 2022-06-08
Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences 2022-06-08
Synklino–Denmark (govt): investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Vaekstfonden 2022-06-08
Synklino–Eir Ventures: investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Eor Vemtures 2022-06-08
Synklino–Maj Invest: investment, 202206 financing round Series A totallling €29.8m incl new + co-investor Maj Invest 2022-06-08
Synklino–Optimum Strategic Communications: public relations, 202206 service existent by Optimum 2022-06-08
Synklino–PKA: investment, 202206 financing round Series A totallling €29.8m incl new + lead investor PKA Pension Fund 2022-06-08
Synklino–SEVERAL: investment, 202206 financing round Series A €29.8m (DKK222m) led by PKA Pension Fund 2022-06-08
Colorifix–SEVERAL: investment, 202205 financing round Series B £18m led by H&M CO:LAB 2022-05-27
Pancryos–Partners HealthCare: drug delivery technology, 202205– license ww excl from BWH for ceMED for delivery of PanINSULA 2022-05-24
Synexa Life Sciences–Gilde Investment: investment, 202205 existent Synexa is backed by Gilde Healthcare 2022-05-19
Syrinx Bioanalytics–Synexa Life Sciences: investment, 202205 acquisition of Syrinx Bioanalytics Oy by Synexa 2022-05-19
Artax Biopharma–SEVERAL: investment, 202205 financing round $26m with new investors Eli Lilly + Sound Bioventures et al 2022-05-11
Artax Biopharma–Sound Bioventures: investment, 202205 financing round totalling $26m incl new investor Sound Bioventures 2022-05-11
Allegro 3D–Bico: investment, 202205 acquisition of Allegro 3D for $6m upfront + $5m milestones in cash 2022-05-05
Sidekick Health–Asabys Partners: investment, 202205 financing round Series B totalling $55m incl co-investor Asabys Partners 2022-05-05
Sidekick Health–Frumtak Ventures: investment, 202205 financing round Series B totalling $55m incl co-investor Frumtak Ventures 2022-05-05
Sidekick Health–Novator Partners: investment, 202205 financing round Series B totalling $55m incl existing + lead investor Novator Ventures 2022-05-05
Sidekick Health–OTHER: investment, 202205 financing round Series B totalling $55m incl co-investor undisclosed US-based strategic investor 2022-05-05
Sidekick Health–SEVERAL: investment, 202205 financing round Series B $55m led by Novator Ventures 2022-05-05
Sidekick Health–Wellington Partners: investment, 202205 financing round Series B totalling $55m incl existing + co-investor Wellington Partners 2022-05-05
Engimmune Therapeutics–SEVERAL: investment, 202205 seed financing round CHF15.5m co-led by Pureos Bioventures + Novo Seeds 2022-05-03
Hemispherian–Meneldor: investment, 202205 seed financing round totalling NOK12.5m ($1.4m) incl lead investor Meneldor 2022-05-03
Hemispherian–SEVERAL: investment, 202205 seed financing round NOK12.5m ($1.4m) led by Meneldor with Norwegian + American investors 2022-05-03
Cinclus Pharma–SEVERAL: investment, 202204–202205 private placement SEK250m with Trill Impact + Eir Ventures I + Irrus Investments + AP4 + Linc 2022-04-19
Labster–Andreessen Horowitz: investment, 202204 financing round Series C 2nd tranche totalling $47m incl existing investor Andreessen Horowitz 2022-04-04
Labster–EduCapital: investment, 202204 financing round Series C 2nd tranche totalling $47m incl existing investor EduCapital 2022-04-04
Labster–GGV Capital: investment, 202204 financing round Series C 2nd tranche totalling $47m incl existing investor GGV Capital 2022-04-04
Labster–NPF Technologies: investment, 202204 financing round Series C 2nd tranche totalling $47m incl existing investor NPF Technologies 2022-04-04
1 2 3 4 5 6 7 8 9 10  next pagenext page



Advertisement

Picture EBD Group Bio-Europe Spring 2023 Basel 560x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x300px

» top